Search research articles
Contact Us
Filters
Showing results (11-20 of 339) with videos related to
Page
of 34
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
January 3, 2009
Does pharmacotherapy reduce the rate of decline of lung function in COPD?
Marc Decramer, Geert Molenberghs
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 10, 2010
Surrogate end points: hopes and perils
Ariel Alonso, Geert Molenberghs
Journal of Biopharmaceutical Statistics
|
October 22, 2013
A multilevel model for hierarchical, repeated, and overdispersed time-to-event outcomes and its estimation strategies
Achmad Efendi, Geert Molenberghs
Test (Madrid, Spain)
|
September 28, 2011
Missing data methods in longitudinal studies: a review
Joseph G Ibrahim, Geert Molenberghs
Journal of Biopharmaceutical Statistics
|
February 26, 2010
Last observation carried forward: a crystal ball?
Michael G Kenward, Geert Molenberghs
Biometrics
|
September 30, 2022
Comparing COVID-19 incidences longitudinally per economic sector against the background of preventive measures and vaccination
Florian Stijven, Johan Verbeeck, Geert Molenberghs
JAMA
|
November 24, 2005
Conflicts of interest and independent data analysis in industry-funded studies
Geert Molenberghs, Peter Imrey, Christiana Drake
Biometrics
|
July 6, 2016
Diagnosing misspecification of the random-effects distribution in mixed models
Reza Drikvandi, Geert Verbeke, Geert Molenberghs
Journal of Biopharmaceutical Statistics
|
July 7, 2007
Estimating reliability and generalizability from hierarchical biomedical data
Geert Molenberghs, Annouschka Laenen, Tony Vangeneugden
Biometrics
|
May 23, 2009
Multiple-imputation-based residuals and diagnostic plots for joint models of longitudinal and survival outcomes
Dimitris Rizopoulos, Geert Verbeke, Geert Molenberghs
Page
of 34
Search research articles
Search
Showing results (11-20 of 339) with videos related to
Sort By:
Page
of 34
American Journal of Respiratory and Critical Care Medicine
|
January 3, 2009
Does pharmacotherapy reduce the rate of decline of lung function in COPD?
Marc Decramer, Geert Molenberghs
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 10, 2010
Surrogate end points: hopes and perils
Ariel Alonso, Geert Molenberghs
Journal of Biopharmaceutical Statistics
|
October 22, 2013
A multilevel model for hierarchical, repeated, and overdispersed time-to-event outcomes and its estimation strategies
Achmad Efendi, Geert Molenberghs
Test (Madrid, Spain)
|
September 28, 2011
Missing data methods in longitudinal studies: a review
Joseph G Ibrahim, Geert Molenberghs
Journal of Biopharmaceutical Statistics
|
February 26, 2010
Last observation carried forward: a crystal ball?
Michael G Kenward, Geert Molenberghs
Biometrics
|
September 30, 2022
Comparing COVID-19 incidences longitudinally per economic sector against the background of preventive measures and vaccination
Florian Stijven, Johan Verbeeck, Geert Molenberghs
JAMA
|
November 24, 2005
Conflicts of interest and independent data analysis in industry-funded studies
Geert Molenberghs, Peter Imrey, Christiana Drake
Biometrics
|
July 6, 2016
Diagnosing misspecification of the random-effects distribution in mixed models
Reza Drikvandi, Geert Verbeke, Geert Molenberghs
Journal of Biopharmaceutical Statistics
|
July 7, 2007
Estimating reliability and generalizability from hierarchical biomedical data
Geert Molenberghs, Annouschka Laenen, Tony Vangeneugden
Biometrics
|
May 23, 2009
Multiple-imputation-based residuals and diagnostic plots for joint models of longitudinal and survival outcomes
Dimitris Rizopoulos, Geert Verbeke, Geert Molenberghs
Page
of 34